Home › Funds › RA CAPITAL MANAGEMENT, L.P. › TSHA
RA CAPITAL MANAGEMENT, L.P. position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 23,555,648 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q2 2026 13F filing — a position valued at US$160.4M, representing 1.39% of its reported portfolio and ranking #18 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed TSHA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s TSHA position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in TSHA in Q3 2023 at 18,472,503 shares (US$58.4M). The position peaked in Q2 2026 at 23,555,648 shares, worth US$160.4M. Across 12 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 23,555,648 shares valued at US$160.4M. Notable position changes include a 41% trim in Q1 2024 (shares fell 22% over the following quarter), a 117% increase in Q2 2025 (shares rose 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 18.47M | $58.37M | New |
| Q4 2023 | 18.47M | $32.70M | Hold |
| Q1 2024 | 10.87M | $31.20M | Reduce |
| Q2 2024 | 10.87M | $24.35M | Hold |
| Q3 2024 | 10.87M | $21.85M | Hold |
| Q4 2024 | 10.87M | $18.81M | Hold |
| Q1 2025 | 10.87M | $15.11M | Hold |
| Q2 2025 | 23.56M | $54.41M | Add |
| Q3 2025 | 23.56M | $77.03M | Hold |
| Q4 2025 | 23.56M | $129.56M | Hold |
| Q1 2026 | 23.56M | $105.29M | Hold |
| Q2 2026 | 23.56M | $160.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 56 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), Vestal Point Capital, LP (US$132.2M), RTW INVESTMENTS, LP (US$92.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- Avoro Capital Advisors LLC 23.89M sh · $162.68M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- RTW INVESTMENTS, LP 13.56M sh · $92.35M · Q2 2026
- Siren, L.L.C. 9.85M sh · $67.06M · Q2 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- GordonMD Global Investments LP 723.18K sh · $24.50M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.04M sh · $20.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 1.99M sh · $13.57M · Q2 2026
- B Group, Inc. 1.80M sh · $12.26M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held TSHA?
RA CAPITAL MANAGEMENT, L.P. has disclosed TSHA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in TSHA?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 23.56M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $160.41M, representing 1.39% of its reported portfolio and ranking #18.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling TSHA?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in TSHA. The position peaked in Q2 2026 at 23.56M shares.
Which other funds hold TSHA?
Other major institutional holders of TSHA include Avoro Capital Advisors LLC, Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.